Sign Up to like & get
recommendations!
0
Published in 2020 at "Bioconjugate chemistry"
DOI: 10.1021/acs.bioconjchem.9b00803
Abstract: γ-Glutamyltranspeptidase (GGT) is a cell membrane-associated enzyme which has been recognized as a promising biomarker for the diagnosis of many malignant tumors. Herein, we rationally designed a fluorine-18 labeled small-molecule probe, [18F]γ-Glu-Cys(StBu)-PPG(CBT)-AmBF3 (18F-1G) by applying…
read more here.
Keywords:
self assembly;
enhancing pet;
probe;
pet imaging ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.7b01607
Abstract: Changes in expression and dysfunctional signaling of TrkA/B/C receptors and oncogenic Trk fusion proteins are found in neurological diseases and cancers. Here, we describe the development of a first 18F-labeled optimized lead suitable for in…
read more here.
Keywords:
trk;
fluorine labeled;
identification 18f;
18f track ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "ACS Chemical Neuroscience"
DOI: 10.1021/acschemneuro.7b00086
Abstract: P-glycoprotein is an efflux transporter located in the blood–brain barrier. (R)-[11C]Verapamil is widely used as a PET tracer to investigate its function in patients with epilepsy, Alzheimer’s disease, and other neurodegenerative diseases. Currently it is…
read more here.
Keywords:
blood brain;
new fluorine;
fluorine labeled;
investigate function ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Frontiers in Chemistry"
DOI: 10.3389/fchem.2017.00124
Abstract: Tumor cells have an increased nutritional demand for amino acids (AAs) to satisfy their rapid proliferation. Positron-emitting nuclide labeled AAs are interesting probes and are of great importance for imaging tumors using positron emission tomography…
read more here.
Keywords:
amino;
fluorine labeled;
imaging tumors;
positron emission ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15050597
Abstract: High expression of prostate-specific membrane antigen (PSMA) in prostate cancers prompted the development of the PSMA-targeted PET-imaging agent [18F]DCFPyL, which was recently approved by the FDA. Fluorine-18-labeled Lys–Urea–Glu-based oxime derivatives of [18F]DCFPyL were prepared for…
read more here.
Keywords:
prostate specific;
prostate;
specific membrane;
fluorine labeled ... See more keywords